Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

Clinical Trial

Offered by: Nemours Children's Health, Jacksonville
Location: Jacksonville, Fla.

Trial Name

SCUSF 0901 Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

 

What is the trial about?

To compare the effects of Modafinil given to children with neurocognitive changes following treatment for brain cancer.

Who can participate?

Age ≥6 years and ≤17 years 10 months at the time of study entry.

What is involved?

Length of study is 10 weeks. Includes neurocognitive tests and physical exam.

Contact Nemours Children's Clinical Trials

Trial Name: SCUSF 0901 Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

IRB# 285283

Is a Clinical Trial Right for Your Child?

Learn more about clinical trials and get answers to questions you might have.

Two researchers in a lab wearing coats and gloves, one looks into a microscope.